BlackRock Science and Technology Term Trust (BSTZ)
Financial Services · Asset Management · NYSE
BlackRock Science and Technology Term Trust (BSTZ) is a Financial Services company in the Asset Management industry. It has a market capitalization of $1.67B and a free-cash-flow yield of 53.4%. Over the most recent reported fiscal year, revenue grew 15.3% and free cash flow per share grew 309.1%. Nama's AI scorecard rates it Buy, 6.5 out of 10. On 12-month momentum it ranks in the rising band of its market.
AI scorecard
Buy · 6.5/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Rising · +37.0% over 12 months ex. last
Second-best fifth of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-44.5%
How far the last close sits under the highest price of the past five years.
BlackRock Science and Technology Term Trust trades disclosed by members of the US House and Senate under the STOCK Act.
See the full Congress trades board →
Member
Chamber
Trade
Amount
Disclosed
Thomas R Carper
Senate
Sell
$1,001 - $15,000
—
John Hoeven
Senate
Buy
$100,001 - $250,000
—
John Hoeven
Senate
Buy
$100,001 - $250,000
—
Thomas R Carper
Senate
Buy
$1,001 - $15,000
—
BSTZ FAQ
Is BSTZ a buy?
Nama's AI scorecard currently rates BlackRock Science and Technology Term Trust Buy (6.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
Is BSTZ Shariah compliant?
Nama's AAOIFI-style screen reads BlackRock Science and Technology Term Trust as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does BSTZ pay a dividend?
Yes — BlackRock Science and Technology Term Trust's dividend yield is 8.0%.